COVID-19 Resources: New Visitor Guidelines | Vaccine Locations | Vaccine Updates
Bayard L. Powell, MD

Bayard L. Powell, MD
Conditions and Treatments
Conditions and Treatments
- CAR T Cell Therapy
- Chronic Myelogenous Leukemia (CML)
- Myelodysplastic Syndromes (MDS)
Ratings and Reviews
4.9181 Ratings 28 Comments |
|
---|---|
CP concern for questions/worries | 4.9 |
CP efforts to include in decisions | 4.9 |
CP explanations of prob/condition | 4.9 |
CP spoke using clear language | 4.9 |
Friendliness/courtesy of CP | 4.9 |
Likelihood of recommending CP | 4.9 |
Patients' confidence in CP | 4.9 |
Time CP spent with patient | 4.9 |
Wait time at clinic | 4.3 |
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Experience Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good.
Patient Comments
- June 11, 2021Dr. Powell is extraordinary. He personally follows up on special tests with a phone call, sometimes late in the day. Most doctors don't take the time to do this!!
- May 31, 2021Dr. Powell has been awesome. very concerned with the severity of my disease. He is always concerned and has even called our home at 9:30 at night. Out thanks to Dr Powell.
- May 17, 2021I have the upmost confidence with Dr. Powell.
- April 26, 2021Excellent doctor. Have complete confidence in.
- April 6, 2021This provider is so good that I look forward to seeing him on my next visit.
- March 29, 2021excellent
- March 26, 2021*Dr. Powell is exceptional in every way possible -
- March 23, 2021t could not ask for a better team
- March 22, 2021I would never want a change. Dr Powell has taken care of me for six years and I trust him 100%
- March 22, 20211st time that I met him. He knew his stuff. He explained himself well. I'd listen to him again.
- March 13, 2021best possible
- March 5, 2021great dr and staff. very concerned about me and very knowledgeable
- February 19, 2021I love *Dr. Powell he is the best and his PA is outstanding!
- February 19, 2021*Dr. Powell is exceptional (his care and genius).
- January 30, 2021Dr. Powell is a very caring, compassionate provider. I pray that the newbies will pay attention and learn from him!
- January 19, 2021Dr. Powell is very caring, friendly, comforting, and communicative. He is the best!
- December 27, 2020THERE IS NO OTHER ABSOLUTELY TRUE CARING COMPASSIONATE CARING ONCOLOGIST AS DR. BAYARD POWELL!I HAVE GROWN SO MUCH IN MIND BODY AND SPIRIT BY HIS EXPERTISE AND SARAH DRALLE AND MEGAN BUMGARNER IN THEIR TEACHING ME ALSO IN MY CANCER DIAGNOSIS !CANCER TREATMENT!CANCER REMISSION!THEY HAVE ALWAYS BEEN THERE FOR ME AND MY FAMILY!
- December 26, 2020I have utmost confidence in Dr. Powell managing my healthcare and cancer related issues.
- November 7, 2020He is excellent in his field.
- October 27, 2020Excellent doctor.
- October 17, 2020A Super Excellent Doctor.
- October 13, 2020I have absolute trust and confidence in Dr. Powell.
- September 28, 2020I truly feel that my health is Dr. Powell's priority. He address all concerns with care, respect and assurances that I may need.
- September 22, 2020I couldn't ask for a better doctor will the patience and understanding he gave us and I would recommend him to everyone.
- September 15, 2020Totally professional, experienced and thorough. Dr. Powell is a gifted physician and among the best in his subspeciality anywhere.
- August 22, 2020Excellent doctor.
- August 18, 2020very good
- August 13, 2020I would say that Dr. Powell is one of the most intelligent and personable physicians I have ever had the pleasure of seeing and journeying through a critical blood cancer. He is a rare gem in the medical field.
Locations
Credentials
Education
- BSE, Duke University, 1976
- MD, University of North Carolina at Chapel Hill School of Medicine, 1980
Residency
- Wake Forest Baptist Medical Center, 1983
Board Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
Memberships
- American College of Physicians
- Cancer and Acute Leukemia Group B.
- American Society of Hematology
- American Society of Clinical Oncology
- Association of Med Schl Professors of Psycholgy
Positions
- Physician
- Section Chief, Hematology and Oncology
- Medical Director for Medical Oncology, Hematology and Oncology
- Professor, Hematology and Oncology
Insurance
This chart is a list of the most common health insurance plans we accept. This list is subject to change. Please check your individual plan to confirm their participation and the coverage allowed.
Due to the different physician groups and hospitals within the Wake Forest Baptist system, physician services and hospital services are billed separately. Please remember that health insurance coverage varies, so some services may not be covered.
If you don’t see your plan or you have questions, please call our Customer Service Center at 877-938-7497. We will do our best to work with you and your plan.
Key
WFUHS - Wake Forest University Health Sciences (professional services)
NCBH - North Carolina Baptist Hospital
LMC - Lexington Medical Center
CHC - Cornerstone Healthcare
Wilkes - Wilkes Regional Medical Center
HPR- High Point Regional
N/A - Not applicable to services provided at facility and/or CHC
NC - Not Contracted, very low to no volume for facility and/or CHC
Wake Forest Baptist Health Managed Care/MA Contracts - January 2019
AETNA (PPO & HMO): Accepted at all locations
AETNA MEDICARE: Accepted at all locations
AETNA WHOLE HEALTH: Accepted at all locations
BCBSNC (PPO & HMO): Accepted at all locations
BLUE MEDICARE: Accepted at all locations
BLUE VALUE: Accepted at all locations
CAROLINA BEHAVIORAL HEALTH: Accepted at WFUHS, NCBH and CHC (not applicable to services provided at Davie, LMC, Wilkes and High Point)
CIGNA: Accepted at all locations
CIGNA BEHAVIORAL HEALTH: Accepted at NCBH and High Point (not applicable to services provided at Davie, LMC, CHC and Wilkes)
CIGNA HEALTHSPRING MEDICARE ADVANTAGE: Accepted at WFUHS, NCBH, Davie, LMC and CHC (not applicable to services provided at Wilkes and High Point)
CIGNA LIFESOURCE (TRANSPLANTS): Accepted at WFUHS and NCBH (not applicable to services provided at Davie, LMC, CHC, Wilkes and High Point)
COVENTRY/WELLPATH: Accepted at all locations
CRESCENT PPO (ASHEVILLE): Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
DIRECT NET: Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
FIRST HEALTH (COVENTRY): Accepted at all locations
FIRSTCAROLINACARE (PINEHURST, NC): Accepted at NCBH (not contracted, very low to no volume for WFUHS, Davie, LMC, CHC, Wilkes and High Point)
GATEWAY HEALTH ALLIANCE (VIRGINIA): Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
GOLDEN RULE INS (UNITED): Accepted at all locations
HEALTHGRAM (formerly PRIMARY PHYSICIAN CARE): Accepted at WFUHS, NCBH and LMC (not contracted, very low to no volume for Davie, CHC, Wilkes and High Point)
HEALTHTEAM ADVANTAGE: Accepted at all locations
HUMANA CHOICECARE: Accepted at all locations
HUMANA MEDICARE ADVANTAGE: Accepted at all locations
LIBERTY ADVANTAGE (MEDICARE ADVANTAGE): Accepted at WFUHS and NCBH (not applicable to services provided at Davie, LMC, CHC, Wilkes and High Point)
MAGELLAN (BEHAVIORAL HEALTH): Accepted at WFUHS, NCBH and CHC (not applicable to services provided at Davie, LMC, Wilkes and High Point)
MEDCOST: Accepted at all locations
MEDCOST ULTRA: Accepted at WFUHS, NCBH, Davie, LMC, Wilkes and High Point (not applicable at CHC)
OPTUMHEALTH (TRANSPLANTS - APPLICABLE TO NCBH/WFUHS ONLY): Accepted at WFUHS and NCBH (not applicable to services provided at Davie, LMC, CHC, Wilkes and High Point)
PREFERRED CARE OF VA INC: Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
SOUTHERN HEALTH SVCS (COVENTRY-PPO ONLY): Accepted at WFUHS, NCBH, Davie and CHC (not contracted, very low to no volume for LMC, Wilkes and High Point)
TWIN COUNTY (VIRGINIA): Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
UNITED BEHAVIORAL HEALTH: Accepted at WFUHS, NCBH, CHC and High Point (not applicable to services provided at Davie, LMC and Wilkes)
UNITED BEHAVIORAL HEALTH INTENSIVE OUTPATIENT PROGRAM (WFUHS ONLY): Accepted at WFUHS (not applicable for services provided at NCBH, Davie, LMC, CHC, Wilkes and High Point)
UNITED HEALTHCARE: Accepted at all locations
UNITED HEALTHCARE MEDICARE: Accepted at all locations
WELLPATH (COVENTRY): Accepted at all locations
LMC ONLY - Contracts specific to support Lexington employer groups, low volume
BEECHSTREET PPO
NATIONAL PROVIDER NETWORK/MEDICAL RESOURCES
PHCS/MULTIPLAN
CHC ONLY - contracts specific to support CHC
AETNA BEHAVIORAL HEALTH
CIGNA BEHAVIORAL HEALTH (limited providers)
THN-TRIAD HEALTH NETWORK MA Plans only (Humana Medicare and Healthteam Advantage)
TRICARE
Key
WFUHS - Wake Forest University Health Sciences (professional services)
NCBH - North Carolina Baptist Hospital
LMC - Lexington Medical Center
CHC - Cornerstone Healthcare
Wilkes - Wilkes Regional Medical Center
HPR- High Point Regional
N/A - Not applicable to services provided at facility and/or CHC
NC - Not Contracted, very low to no volume for facility and/or CHC
Research
- Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia. Walker CJ, Kohlschmidt J, Eisfeld AK, Mrózek K, Liyanarachchi S, Song C, Nicolet D, Blachly JS, Bill M, Papaioannou D, Oakes CC, Giacopelli B, Genutis LK, Maharry SE, Orwick S, Archer KJ, Powell BL, Kolitz JE, Uy GL, Wang ES, Carroll AJ, Stone RM, Byrd JC, de la Chapelle A, Bloomfield CD. Clin. Cancer Res. 2019 11; 25(21):6524-6531.
- Goals and Adverse Effects: Rate of Concordance Between Patients and Providers. Duckworth KE, Morrell R, Russell GB, Powell B, Canzona M, Lichiello S, Riffle O, Tolbert A, McQuellon R. J Oncol Pract. 2019 09; 15(9):e798-e806.
- Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. Loh KP, Tooze JA, Nicklas BJ, Kritchevsky SB, Williamson JD, Ellis LR, Powell BL, Pardee TS, Goyal NG, Klepin HD. J Geriatr Oncol. 2020 04; 11(3):410-416.
- Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically. Mrózek K, Eisfeld AK, Kohlschmidt J, Carroll AJ, Walker CJ, Nicolet D, Blachly JS, Bill M, Papaioannou D, Wang ES, Uy GL, Kolitz JE, Powell BL, Blum W, Stone RM, Byrd JC, Bloomfield CD. Leukemia. 2019 07; 33(7):1620-1634.
- Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance). Roboz GJ, Mandrekar SJ, Desai P, Laumann K, Walker AR, Wang ES, Kolitz JE, Powell BL, Attar EC, Stock W, Bloomfield CD, Kohlschmidt J, Mrózek K, Hassane DC, Garraway L, Jané-Valbuena J, Baltay M, Tracy A, Marcucci G, Stone RM, Larson RA. Blood Adv. 2018 12; 2(24):3608-3617.
- A study on the effectiveness of the drug inotuzumab ozogamicin in combination with standard chemotherapy in patients with B-Cell Acute Lymphoblastic Leukemia.
- Study of the drugs Ozogamicin and Blinatumomab for treatment of Acute Lymphoblastic Leukemia
- A study of the drug asciminib (ABL001) in previously treated patients with chronic myeloid leukemia